CLINICAL STUDY: ENDOCARDITIS
Risk of embolization after institution of antibiotic therapy for infective endocarditis
Isidre Vilacosta, MD*,*,
Catherine Graupner, MD*,
JoséAlberto SanRomán, MD ,
Cristina Sarriá, MD ,
Ricardo Ronderos, MD ,
Cristina Fernández, MD*,
Leonardo Mancini, MD,
Olga Sanz, MD,
JuanVictor Sanmartín, MD and
Walter Stoermann, MD||
* Hospital Universitario San Carlos, Madrid, Spain
Hospital Universitario de Valladolid, Valladolid, Spain
Hospital de la Princesa, Madrid, Spain
Hospital San Juan de Dios, La Plata, Argentina
|| CIMAC, San Juan, Argentina
Manuscript received June 19, 2001;
revised manuscript received January 28, 2002,
accepted February 6, 2002.
* Reprint requests and correspondence: Dr. Isidre Vilacosta, Instituto de Cardología, Hospital Universitario de San Carlos, 28040, Madrid, Spain.
ivilac{at}medynet.com
OBJECTIVES: This study was designed to assess the risk of systemic embolization in patients with left-sided infective endocarditis, once adequate antibiotic treatment had been initiated, on the basis of prospective clinical follow-up.
BACKGROUND: As one of the complications of infective endocarditis, embolization has a great impact on prognosis. Prediction of an individual patient’s risk of embolization is very difficult.
METHODS: We studied 217 episodes of left-sided endocarditis that were experienced among a cohort of 211 prospectively recruited patients. According to the Duke criteria, 91% of the episodes were definite infective endocarditis. Seventy-two episodes involved infections located on prosthetic valves. All patients were studied by transthoracic and transesophageal echocardiography. Clinical, echocardiographic and microbiologic data were entered in a data base. The mean follow-up interval was 151 days.
RESULTS: Twenty-eight episodes (12.9%; group I) of endocarditis had embolic events after the initiation of antibiotic therapy. The remaining 189 episodes did not embolize (group II). Most emboli (52%) affected the central nervous system, and 65% of the embolic events occurred during the first two weeks after initiation of antibiotic therapy. Previous embolism was associated with new embolism (relative risk [RR] 1.73, 95% confidence interval [CI] 1.02 to 2.93; p = 0.05). There was an increase in the risk of embolization with increasing vegetation size (RR 3.77, 95% CI 0.97 to 12.57; p = 0.07). Vegetation size had no impact on the risk of embolization in streptococcal endocarditis or aortic infection. By contrast, large ( 10 mm) vegetations had a higher incidence of embolism when the microorganism was staphylococcus (p = 0.04) and the mitral valve was infected (p = 0.03). The increase in vegetation size at follow-up showed a higher risk for embolization (RR 2.64, 95% CI 0.98 to 7.16; p = 0.02).
CONCLUSIONS: Embolism before antimicrobial therapy is a risk factor for new emboli. The risk of embolization seems to increase with increasing vegetation size, and this is particularly significant in mitral endocarditis and staphylococcal endocarditis. An increase in vegetation size, despite antimicrobial treatment, may predict later embolism.
|
Abbreviations and Acronyms
| | CI | | confidence interval | | RR | | relative risk | | TEE | | transesophageal echocardiography | | TTE | | transthoracic echocardiography |
|
This article has been cited by other articles:
|
|
|
|
 
Endorsed by the European Society of Clinical Micro, Authors/Task Force Members, G. Habib, B. Hoen, P. Tornos, F. Thuny, B. Prendergast, I. Vilacosta, P. Moreillon, M. de Jesus Antunes, et al.
Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): The Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC)
Eur. Heart J.,
October 1, 2009;
30(19):
2369 - 2413.
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. A. Cooper, E. C. Thompson, R. Laureno, A. Fuisz, A. S. Mark, M. Lin, and S. A. Goldstein
Subclinical Brain Embolization in Left-Sided Infective Endocarditis: Results From the Evaluation by MRI of the Brains of Patients With Left-Sided Intracardiac Solid Masses (EMBOLISM) Pilot Study
Circulation,
August 18, 2009;
120(7):
585 - 591.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. S. Baman, S. K. Gupta, J. A. Valle, and E. Yamada
Risk Factors for Mortality in Patients With Cardiac Device-Related Infection
Circ Arrhythm Electrophysiol,
April 1, 2009;
2(2):
129 - 134.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. M. Feuchtner, P. Stolzmann, W. Dichtl, T. Schertler, J. Bonatti, H. Scheffel, S. Mueller, A. Plass, L. Mueller, T. Bartel, et al.
Multislice computed tomography in infective endocarditis comparison with transesophageal echocardiography and intraoperative findings.
J. Am. Coll. Cardiol.,
February 3, 2009;
53(5):
436 - 444.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I M Tleyjeh, J M Steckelberg, G Georgescu, H M K Ghomrawi, T L Hoskin, F B Enders, F Mookadam, W C Huskins, W R Wilson, and L M Baddour
The association between the timing of valve surgery and 6-month mortality in left-sided infective endocarditis
Heart,
July 1, 2008;
94(7):
892 - 896.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. N. Salem, P. T. O'Gara, C. Madias, and S. G. Pauker
Valvular and Structural Heart Disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Chest,
June 1, 2008;
133(6_suppl):
593S - 629S.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L Liao, D F Kong, Z Samad, P A Pappas, J G Jollis, S S Lin, A Wang, V G Fowler Jr, V H Chu, D J Sexton, et al.
Echocardiographic risk stratification for early surgery with endocarditis: a cost-effectiveness analysis
Heart,
May 1, 2008;
94(5):
e18 - e18.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Revilla, J. Lopez, I. Vilacosta, E. Villacorta, M. J. Rollan, J. R. Echevarria, Y. Carrascal, S. Di Stefano, E. Fulquet, E. Rodriguez, et al.
Clinical and prognostic profile of patients with infective endocarditis who need urgent surgery
Eur. Heart J.,
January 1, 2007;
28(1):
65 - 71.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Thuny, G. Disalvo, O. Belliard, J.-F. Avierinos, V. Pergola, V. Rosenberg, J.-P. Casalta, J. Gouvernet, G. Derumeaux, D. Iarussi, et al.
Risk of Embolism and Death in Infective Endocarditis: Prognostic Value of Echocardiography: A Prospective Multicenter Study
Circulation,
July 5, 2005;
112(1):
69 - 75.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. M. Baddour, W. R. Wilson, A. S. Bayer, V. G. Fowler Jr, A. F. Bolger, M. E. Levison, P. Ferrieri, M. A. Gerber, L. Y. Tani, M. H. Gewitz, et al.
Infective Endocarditis: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Statement for Healthcare Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: Endorsed by the Infectious Diseases Society of America
Circulation,
June 14, 2005;
111(23):
e394 - e434.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. P Sengupta and B. K Khandheria
Transoesophageal echocardiography
Heart,
April 1, 2005;
91(4):
541 - 547.
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. N. Salem, P. D. Stein, A. Al-Ahmad, H. I. Bussey, D. Horstkotte, N. Miller, and S. G. Pauker
Antithrombotic Therapy in Valvular Heart Disease--Native and Prosthetic: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Chest,
September 1, 2004;
126(3_suppl):
457S - 482S.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. H. Chu, C. H. Cabell, D. K. Benjamin Jr, E. F. Kuniholm, V. G. Fowler Jr, J. Engemann, D. J. Sexton, G. R. Corey, and A. Wang
Early Predictors of In-Hospital Death in Infective Endocarditis
Circulation,
April 13, 2004;
109(14):
1745 - 1749.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Homma and C. Grahame-Clarke
Reply
J. Am. Coll. Cardiol.,
March 17, 2004;
43(6):
1134 - 1134.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Homma and C. Grahame-Clarke
Toward reducing embolic complications from endocarditis
J. Am. Coll. Cardiol.,
September 3, 2003;
42(5):
781 - 783.
[Full Text]
[PDF]
|
|
|
|
